(AMCX) AMC Networks - Overview
Stock: Programming, Streaming, Films, Venues
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 56.9% |
| Relative Tail Risk | -5.05% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.28 |
| Alpha | -34.37 |
| Character TTM | |
|---|---|
| Beta | 0.954 |
| Beta Downside | 1.021 |
| Drawdowns 3y | |
|---|---|
| Max DD | 79.54% |
| CAGR/Max DD | -0.31 |
Description: AMCX AMC Networks December 30, 2025
AMC Networks Inc. (NASDAQ:AMCX) is a diversified entertainment company that distributes content across the United States, Europe, and other international markets. It operates two primary segments: Domestic Operations, which includes linear networks such as AMC, BBC America, and SundanceTV, as well as subscription-streaming services (Acorn TV, Shudder, Sundance Now, ALLBLK, HIDIVE, and AMC+); and International, which runs the AMCNI channel portfolio and comedy-venue business under the Levity brand. The firm also produces and licenses original programming and conducts film distribution through IFC Films, RLJ Entertainment Films, and Shudder.
Key recent data points (Q3 2024) show total revenue of roughly $1.48 billion, with streaming services contributing about 23 % of that figure and growing at a 12 % year-over-year rate. The domestic subscriber base is estimated at ~5 million, delivering an average revenue per user (ARPU) near $9.5 per month, while advertising revenue remains sensitive to macro-economic cycles, especially discretionary consumer spending and corporate marketing budgets. A sector-wide driver is the continued cord-cutting trend, which pressures linear network ad rates but simultaneously fuels demand for niche, ad-supported streaming (AVOD) and premium SVOD offerings.
For a deeper quantitative view of AMC Networks’ valuation metrics, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -139.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -1.10 > 1.0 |
| NWC/Revenue: 34.60% < 20% (prev 38.40%; Δ -3.80% < -1%) |
| CFO/TA 0.07 > 3% & CFO 312.2m > Net Income -139.6m |
| Net Debt (1.28b) to EBITDA (1.09b): 1.18 < 3 |
| Current Ratio: 2.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (56.4m) vs 12m ago 0.47% < -2% |
| Gross Margin: 51.01% > 18% (prev 0.50%; Δ 5051 % > 0.5%) |
| Asset Turnover: 51.28% > 50% (prev 51.83%; Δ -0.55% > 0%) |
| Interest Coverage Ratio: 0.95 > 6 (EBITDA TTM 1.09b / Interest Expense TTM 347.1m) |
Altman Z'' 4.16
| A: 0.19 (Total Current Assets 1.52b - Total Current Liabilities 715.8m) / Total Assets 4.21b |
| B: 0.53 (Retained Earnings 2.23b / Total Assets 4.21b) |
| C: 0.07 (EBIT TTM 329.6m / Avg Total Assets 4.52b) |
| D: 0.66 (Book Value of Equity 2.01b / Total Liabilities 3.07b) |
| Altman-Z'' Score: 4.16 = AA |
Beneish M -3.26
| DSRI: 0.95 (Receivables 571.6m/647.6m, Revenue 2.32b/2.50b) |
| GMI: 0.97 (GM 51.01% / 49.63%) |
| AQI: 0.98 (AQ_t 0.60 / AQ_t-1 0.61) |
| SGI: 0.93 (Revenue 2.32b / 2.50b) |
| TATA: -0.11 (NI -139.6m - CFO 312.2m) / TA 4.21b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of AMCX shares?
Over the past week, the price has changed by -1.04%, over one month by -14.84%, over three months by +5.24% and over the past year by -19.00%.
Is AMCX a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 2
- Sell: 1
- StrongSell: 3
What are the forecasts/targets for the AMCX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7 | -8.3% |
| Analysts Target Price | 7 | -8.3% |
| ValueRay Target Price | 6 | -21.2% |
AMCX Fundamental Data Overview February 03, 2026
P/S = 0.1449
P/B = 0.3187
P/EG = 1.7554
Revenue TTM = 2.32b USD
EBIT TTM = 329.6m USD
EBITDA TTM = 1.09b USD
Long Term Debt = 1.91b USD (from longTermDebt, last quarter)
Short Term Debt = 41.3m USD (from shortTermDebt, last quarter)
Debt = 2.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.28b USD (from netDebt column, last quarter)
Enterprise Value = 1.61b USD (335.6m + Debt 2.00b - CCE 716.8m)
Interest Coverage Ratio = 0.95 (Ebit TTM 329.6m / Interest Expense TTM 347.1m)
EV/FCF = 6.04x (Enterprise Value 1.61b / FCF TTM 267.2m)
FCF Yield = 16.55% (FCF TTM 267.2m / Enterprise Value 1.61b)
FCF Margin = 11.53% (FCF TTM 267.2m / Revenue TTM 2.32b)
Net Margin = -6.03% (Net Income TTM -139.6m / Revenue TTM 2.32b)
Gross Margin = 51.01% ((Revenue TTM 2.32b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 48.18% (prev 52.69%)
Tobins Q-Ratio = 0.38 (Enterprise Value 1.61b / Total Assets 4.21b)
Interest Expense / Debt = 10.84% (Interest Expense 216.3m / Debt 2.00b)
Taxrate = 34.81% (42.8m / 122.8m)
NOPAT = 214.8m (EBIT 329.6m * (1 - 34.81%))
Current Ratio = 2.12 (Total Current Assets 1.52b / Total Current Liabilities 715.8m)
Debt / Equity = 1.90 (Debt 2.00b / totalStockholderEquity, last quarter 1.05b)
Debt / EBITDA = 1.18 (Net Debt 1.28b / EBITDA 1.09b)
Debt / FCF = 4.79 (Net Debt 1.28b / FCF TTM 267.2m)
Total Stockholder Equity = 942.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.09% (Net Income -139.6m / Total Assets 4.21b)
RoE = -14.82% (Net Income TTM -139.6m / Total Stockholder Equity 942.2m)
RoCE = 11.55% (EBIT 329.6m / Capital Employed (Equity 942.2m + L.T.Debt 1.91b))
RoIC = 6.84% (NOPAT 214.8m / Invested Capital 3.14b)
WACC = 7.41% (E(335.6m)/V(2.33b) * Re(9.43%) + D(2.00b)/V(2.33b) * Rd(10.84%) * (1-Tc(0.35)))
Discount Rate = 9.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 13.29%
[DCF Debug] Terminal Value 83.22% ; FCFF base≈304.0m ; Y1≈375.0m ; Y5≈638.6m
Fair Price DCF = 342.7 (EV 12.26b - Net Debt 1.28b = Equity 10.98b / Shares 32.0m; r=7.41% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -93.14 | EPS CAGR: -56.23% | SUE: -1.66 | # QB: 0
Revenue Correlation: -80.00 | Revenue CAGR: -9.11% | SUE: 0.76 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.57 | Chg30d=+0.064 | Revisions Net=-1 | Analysts=4
EPS next Year (2026-12-31): EPS=1.92 | Chg30d=-0.126 | Revisions Net=+1 | Growth EPS=-6.2% | Growth Revenue=-2.3%